Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, As Represented By”

2,152 pharma patents match "The United States of America, As Represented By" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,152
Index total 30,257
Page 45 / 90

Quick answer

This filtered view shows 2,152 pharmaceutical patents matching "The United States of America, As Represented By" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,152 results for “The United States of America, As Represented By” · 30,257 patents in full index Clear search

  1. US 9084819

    Magnetic microstructures for magnetic resonance imaging

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted

  2. US 9074185

    Adoptive cell therapy with young T cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 7, 2015 · Expires Jul 2, 2035

    granted

  3. US 9072716

    Methods of treating and preventing inflammatory bowel disease involving IL-13 and NKT cells

    The United States of America, as represented by the Secretary Department of Health by Human Servies · Granted Jul 7, 2015 · Expires Jul 2, 2035

    granted

  4. US 9066965

    Purified limonin glucoside for prevention and treatment of chronic diseases

    The United States of America, as represented by the Secretary of Agriculture · Granted Jun 30, 2015 · Expires Jun 25, 2035

    granted

  5. US 9066948

    Oxadiazolo[3,2-a]pyrimidines and thiadiazolo[3,2-a]pyrimidines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 30, 2015 · Expires Jun 25, 2035

    granted

  6. US 9056891

    Synthetic peptide inhibitors of Wnt pathway

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 16, 2015 · Expires Jun 11, 2035

    granted

  7. US 9056068

    Vaccine and methods of use against Strongyloide stercoralis infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 16, 2015 · Expires Jun 11, 2035

    granted

  8. US 9056907

    Human domain antibodies against components of the human insulin-like growth factor (IGF) system

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 16, 2015 · Expires Jun 11, 2035

    granted

  9. US 9044451

    Use of delta tocopherol for the treatment of lysosomal storage disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 2, 2015 · Expires May 28, 2035

    granted

  10. US 9044509

    Inhibition of HIV infection through chemoprophylaxis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 2, 2015 · Expires May 28, 2035

    granted

  11. US 9034343

    Attenuated human parainfluenza virus, methods and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 19, 2015 · Expires May 14, 2035

    granted

  12. US 9028887

    Method improve spatial memory via pterostilbene administration

    The United States of America, as represented by the Secretary of Agriculture · Granted May 12, 2015 · Expires May 7, 2035

    granted

  13. US 9029344

    Linked purine pterin HPPK inhibitors useful as antibacterial agents

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 12, 2015 · Expires May 7, 2035

    granted

  14. US 9018371

    Adenosine derivatives, method for the synthesis thereof, and the pharmaceutical compositions for the prevention and treatment of the inflammatory diseases containing the same as an active ingredient

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  15. US 9018227

    Nicotinic acetylcholine receptor agonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  16. US 9012223

    Methods for enhancing genome stability and telomere elongation in embryonic stem cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  17. US 9012647

    Nitroxide modified non-steroidal anti-inflammatory compounds and uses thereof in the treatment and prevention of diseases or disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  18. US 8999290

    Papillomavirus pseudoviruses for detection and therapy of tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 7, 2015 · Expires Apr 2, 2035

    granted

  19. US 8999336

    Monoclonal antibodies against Orthopoxviruses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 7, 2015 · Expires Apr 2, 2035

    granted

  20. US 8999352

    Genetically engineered swine influenza virus and uses thereof

    The United States of America, as represented by the Secretary of Agriculture · Granted Apr 7, 2015 · Expires Apr 2, 2035

    granted

  21. US 8993768

    Tropolone compounds for treating or preventing retroviral infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted

  22. US 8993626

    Methods of treatment using sterculic acid

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted

  23. US 8992943

    Vaccine for protection against Shigella sonnei disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted

  24. US 8986757

    Essential oils inhibit mold on wood

    The United States of America, as represented by the Secretary of Agriculture · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.